| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3856117 | Journal of Renal Nutrition | 2009 | 7 Pages |
Abstract
Short-term parenteral administration of Ï-3 PUFA is safe and well-tolerated by HD patients. The intervention does not significantly influence markers of inflammation or change the nutritional status of chronic HD patients, but it may attenuate the inflammatory response to HD sessions.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Magdalena MD, Jolanta MD, Danuta MD, Andrzej MD, StanisÅaw MD, MichaÅ MD,